Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Bullboard Posts
Post by mcv1on Apr 13, 2015 11:50am
337 Views
Post# 23623395

Wacko market behavior last week

Wacko market behavior last weekIt seems like most of the investors of this stock have no idea of their business.

They have no PATENTED products.  Perhaps this needs to said slower for the slow people here.

t-h-e-y  h-a-v-e  n-o-o-o  p-a-t-e-n-t-e-d  p-r-o-d-u-c-t-s.

The fact that another company is developing a similar product simply proves the market.  Feramax represents a tiny part of the iron market in Canada.  There is no issue of generic that only applies to patent products.  There are dozens of competing products - one more doesn't matter.  It has no effect on their business and if anything may even help because of more awareness of their proven superior product.

It was expected Feramax would peak a year or 2 ago.  It still hasn't happened.  When it peaks it will continue to be a cash cow for decades.  Lots of other products now and lots more in development.

Anything under $10 is a cheap price for this stock.  Once earnings come out next month all this silliness will be forgotten.  Good buying opportunity.


Bullboard Posts